← Back
$NAMS All transactions

NewAmsterdam Pharma Co N.V.

▼ SELL 10b5-1 Plan

$ Value

$823K

Shares

24,362

Price

$34

Filed

Jan 22

Insider

Name

Somaiya Mayur Ian

Title

Chief Financial Officer

CIK

0001760303

Roles

Officer

Transaction Details

Transaction Date

2026-01-21

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

58,382

Footnotes

This transaction was effected pursuant to a trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. | These shares were sold in multiple transactions at prices ranging from $30.17 per share to $30.85 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | These shares were sold in multiple transactions at prices ranging from $31.29 per share to $32.28 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | These shares were sold in multiple transactions at prices ranging from $32.29 per share to $32.58 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | These shares were sold in multiple transactions at prices ranging from $32.48 per share to $33.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | These shares were sold in multiple transactions at prices ranging from $33.48 per share to $34.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each transaction. | The option was granted on November 1, 2023. 25% of the shares underlying the option vested on the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Filing Info

Accession No.

0001193125-26-019686

Form Type

4

Issuer CIK

0001936258

Somaiya Mayur Ian's History

Date Ticker Type Value
2026-01-21 NAMS M $368K
2026-01-21 NAMS $513K
2026-01-21 NAMS $823K
2026-01-21 NAMS M $0
2026-01-20 NAMS M $558K
2026-01-20 NAMS $28K
2026-01-20 NAMS $1.3M
2026-01-20 NAMS $635K
2026-01-20 NAMS M $0
2026-01-07 NAMS A

Other Insiders at NAMS (90d)

Insider Bought Sold Last
Kooij Louise Frederika
Chief Accounting Officer
$4.8M 2026-01-28